
Sign up to save your podcasts
Or


What happens to the chemicals we use in everyday life once they enter the environment?
In this episode, I am joined by Dr. Irene Bramke, Senior Environmental Risk Assessor at AstraZeneca.
Irene and I have a detailed discussion about persistence (how long it takes for chemicals to break down in the environment). With recent concerns around plastic pollution, PFAS 'forever chemicals', and broader sustainability goals, the persistence of chemicals in the environment has become one of the most urgent and pressing issues for policymakers and society.
Irene and I discuss the science behind persistence, and how it relates to the risks chemicals might pose to people and the environment. We also talk about recent regulatory developments in Europe, and how these are reshaping the future of chemicals management.
Our conversation covers:
PBT/PMT assessment of active pharmaceutical ingredients - ScienceDirect
Environmental fate and effects assessment of human pharmaceuticals: lessons learnt from regulatory data | Environmental Sciences Europe
Overcoming challenges and advancing (bio)degradation guidelines: OECD TG309 revisited - ECETOC
AstraZeneca - EcoPharmacoVigilance Dashboard
Using environmental concentration exposure datasets in environmental assessments: The development of Criteria for Reporting and Evaluating Exposure Datasets (CREED): Integrated Environmental Assessment and Management
HOMEPAGE - imi-premier
Modernizing assessment of persistence and transformation products of chemicals – from new tools to implementation (23-October 24, 2025): Overview · HIFIS and Helmholtz Events (Indico)
Visit my website for more content and insights www.embarkchemical.com
Support the show
By Chris HughesWhat happens to the chemicals we use in everyday life once they enter the environment?
In this episode, I am joined by Dr. Irene Bramke, Senior Environmental Risk Assessor at AstraZeneca.
Irene and I have a detailed discussion about persistence (how long it takes for chemicals to break down in the environment). With recent concerns around plastic pollution, PFAS 'forever chemicals', and broader sustainability goals, the persistence of chemicals in the environment has become one of the most urgent and pressing issues for policymakers and society.
Irene and I discuss the science behind persistence, and how it relates to the risks chemicals might pose to people and the environment. We also talk about recent regulatory developments in Europe, and how these are reshaping the future of chemicals management.
Our conversation covers:
PBT/PMT assessment of active pharmaceutical ingredients - ScienceDirect
Environmental fate and effects assessment of human pharmaceuticals: lessons learnt from regulatory data | Environmental Sciences Europe
Overcoming challenges and advancing (bio)degradation guidelines: OECD TG309 revisited - ECETOC
AstraZeneca - EcoPharmacoVigilance Dashboard
Using environmental concentration exposure datasets in environmental assessments: The development of Criteria for Reporting and Evaluating Exposure Datasets (CREED): Integrated Environmental Assessment and Management
HOMEPAGE - imi-premier
Modernizing assessment of persistence and transformation products of chemicals – from new tools to implementation (23-October 24, 2025): Overview · HIFIS and Helmholtz Events (Indico)
Visit my website for more content and insights www.embarkchemical.com
Support the show